Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients.

ABSTRACT:

SUBMITTER: Alberelli MA 

PROVIDER: S-EPMC5830396 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature